|
|
Article: CVS Caremark Applauds FTC's Leadership on Follow-on Biologics.
- Article from:
- PR Newswire
- Article date:
- November 21, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Calls on Congress to Move Swiftly to Provide Patients and Payors Access and Savings
WOONSOCKET, R.I., Nov. 21 /PRNewswire/ -- CVS Caremark today applauded the Federal Trade Commission (FTC) for holding a public Roundtable to address issues of competition and continued innovation under a framework for follow-on biologic drugs.
"CVS Caremark serves millions of patients, many of whom depend on specialty drugs to provide life-saving and life-enhancing treatments for their serious conditions. We support the creation of a federal legislative pathway for FDA approval of these medicines to provide access and savings to patients and payors," said Dave Golding, ...